Navigation Links
Temple's Dr. Steven Houser recognized by the American Heart Association
Date:11/20/2013

(Philadelphia, PA) Steven R. Houser, PhD, FAHA, Director of the Cardiovascular Research Center (CVRC) at Temple University School of Medicine, has been studying the heart for nearly three and a half decades. Over that time, he has made significant contributions to cardiovascular research, work that led to his recent recognition with two prestigious honors from the American Heart Association (AHA) the Basic Cardiovascular Science (BCVS) Council Distinguished Achievement Award and the Thomas W. Smith Memorial Lecture Award. Dr. Houser received the awards at the AHA Scientific Sessions 2013 meeting held Nov. 16‒20 in Dallas, Texas.

"It's an honor," Houser said of being chosen as the recipient of the two awards, which are given to top scientists who have committed their careers to cardiovascular science and fulfilling the aims of the AHA.

"Steve has been a leader for his whole career in advancing our understanding of how calcium regulates the beating of the heart cell," said Walter J. Koch, PhD, Professor and Chairman of the Department of Pharmacology at Temple University School of Medicine (TUSM). "His data has guided a generation of scientists in probing mechanisms for why the heart fails. He has stayed on the cutting-edge of this field for over 25 years, and now he is delving into why calcium can also harm the heart and is active in pursuit of novel regenerative pathways to repair the failing heart."

"This excellence has not gone unnoticed by colleagues at the AHA," Koch added.

Houser began his influential career when he joined the faculty at Temple in 1978. He received his first AHA grant two years later. "At the time, not much was known about how heart cells work," Houser explained.

But Houser quickly positioned himself at the leading edge of basic cardiovascular research by exploringand answeringfundamental questions about heart cell function. He investigated reasons why the heart does not function properly in diseases such as hypertension and ischemic heart failure, which results from an insufficient flow of oxygen to the heart muscle. And he tested novel approaches to the prevention and treatment of those conditions. He made major advances in the scientific understanding of fundamental cardiac function, and he identified molecular defects that contribute to cardiac dysfunction.

Houser's research and his recruitment of key researchers to Temple contributed to the establishment of its reputation as a leader in cardiovascular research. Importantly, he worked to create the CVRC, which opened in 2003, and which he has directed since that time. He also was instrumental in the recruitment of Dr. Koch, who, along with Houser's assistance, developed the Center for Translational Medicine at Temple University School of Medicine, which Koch now directs.

Most recently, Houser and his team have explored ways to repair damaged heart tissue using cell therapyresearch that led to the discovery that bone-derived stem cells are better at regenerating heart tissue than the heart's own stem cells. His team's paper on that breakthrough, which was published online in June 2013 in Circulation Research, is now among the journal's most downloaded papers. Because of its success, Houser was invited to deliver a talk on the research at Scientific Sessions 2013.

The BCVS Distinguished Achievement Award and the Thomas W. Smith Memorial Lecture Award were given to Houser for his research accomplishments, but he has also devoted much time to the AHA. For 2013‒2014 he is Chairperson of the AHA Research Committee, which reviews, selects, and funds research grants, and is on the organization's Board of Directors.

Houser delivered the Thomas W. Smith Memorial Lecture the morning of Nov. 18.

In addition to directing Temple's Cardiovascular Research Center, Houser is Chairperson of the Department of Physiology, the Laura H. Carnell Professor of Physiology, and a Professor of Medicine at TUSM.


'/>"/>

Contact: Jeremy Walter
Jeremy.Walter@tuhs.temple.edu
215-707-7882
Temple University Health System
Source:Eurekalert

Related biology news :

1. Patel recognized with NSF Career Award for computer-modeling research on cell membranes
2. Research warns Asia unlikely to achieve climate, poverty goals unless womens rights are recognized
3. Micross Components Recognized as Teledyne Electronic Manufacturing Services Manufacturer of the Year
4. ONR-funded young innovators recognized by President
5. UC Riverside entomologist recognized for research in citrus entomology
6. Coral researcher recognized with prestigious award
7. 60th anniversary of NSF Grad Research Fellowship Program; UM fellow Staatermans video recognized
8. PNNL recognized for transferring innovations to the marketplace
9. UC Riverside mathematicians recognized by American Mathematical Society
10. 3 Johns Hopkins researchers recognized for medical inventions
11. Joint air toxics research project among tribes, agencies recognized for partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... PANAMA CITY , Jan. 26, 2017  Crossmatch, ... today unveiled a new solution aimed at combatting fraud, ... The solution was introduced at the Action on Disaster ... a key meeting point for UN agencies and foreign ... Fraud, waste and abuse are a largely ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
Breaking Biology Technology: